Diabetes Care Stocks List

Diabetes Care Stocks Recent News

Date Stock Title
May 3 NVO Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 TNDM Why Tandem Diabetes Stock Just Jumped 22%
May 3 NVO Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
May 3 NVO Analyst unveils Amgen stock price target after weight-loss drug data
May 3 NVO The FTC Cracks Down On Novo Nordisk's Ozempic
May 3 TNDM Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2024 Earnings Call Transcript
May 3 NVO Weight-loss drug competition heats up. Is Wegovy in trouble?
May 3 NVO Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3 NVO Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
May 3 TNDM Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
May 3 NVO FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
May 3 TNDM Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
May 3 NVO Catalent, Novo Nordisk receive FTC request for more information
May 3 NVO US FTC seeks more information on Novo Nordisk parent-Catalent deal
May 3 NVO UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
May 3 NVO Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
May 3 TNDM Q1 2024 Tandem Diabetes Care Inc Earnings Call
May 3 NVO How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
May 3 NVO This Is a Huge Sigh of Relief for Novo Nordisk Investors
May 3 NVO Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
Diabetes Care

Diabetes Care is a monthly peer-reviewed medical journal published since 1978 by the American Diabetes Association. The journal covers research in the following five categories: 1) clinical care/education/nutrition/psychosocial research, 2) epidemiology/health services research, 3) emerging treatments and technologies, 4) pathophysiology/complications, and 5) cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries.According to the Journal Citation Reports, the journal has a 2017 impact factor of 13.397 ranking it fifth out of 138 journals in the category "Endocrinology & Metabolism."

Browse All Tags